Global mRNA Vaccines & Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.8% over the forecast period 2022-2028. Messenger Ribonucleic Acid (mRNA) is a single protein-coding gene found in the genome that serves as the foundation for protein synthesis in cells. mRNA vaccines and treatments are made in labs utilizing mammalian cells and have favorable immunological characteristics. non-replicating, in vivo self-replicating, Self-amplifying, and in vitro dendritic cell non-replicating mRNA are some of the most frequent forms of vaccines and treatments. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. By increasing B- and T-cell responses contribute to improving the body's immunity. The market growth is driven by key factors such as rise in prevalence of cancer and increase in awareness about vaccination. According to Statista, Breast cancer was the most common cancer form in 2020, with roughly 48 women diagnosed per 100,000 people. Prostate cancer had a 12-month prevalence rate of 30.4 per 100,000 people at the time. However, growing demand for therapeutic medicines impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global mRNA Vaccines & Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. in which, North America is leading the market share and is expected to be the fastest growing region in the forecast years. Factors supporting the market growth are the plentiful presence of prominent players & exponentially surging number of COVID-19 patients in the US.
Major market players included in this report are:
- Arcturus Therapeutics Holdings Inc.
- Providence Therapeutics
- CureVac N.V.
- GlaxoSmithKline plc
- Pantherna Therapeutics GmbH
- Silence Therapeutics
- Ethris GmbH
- BioNTech
- Versameb AG
- Gennova Biopharmaceuticals Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and mRNA Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By mRNA Type:
- Nucleoside-Modified mRNA (modRNA)
- Unmodified mRNA
- Self-Amplifying mRNA
By Application:
- COVID mRNA Application
- Non-COVID mRNA Application
By End-User:
- Hospitals & healthcare Clinics
- Research Organisation & Institutions
- Others
By Region:
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
Furthermore, years considered for the study are as follows:
- Historical year - 2018, 2019, 2020
- Base year - 2021
- Forecast period - 2022 to 2028
Target Audience of the Global mRNA vaccines & therapeutics Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. mRNA Vaccines and Therapeutics Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. mRNA Vaccines and Therapeutics Market, by MRNA Type, 2020-2028 (USD Billion)
- 1.2.3. mRNA Vaccines and Therapeutics Market, by Application, 2020-2028 (USD Billion)
- 1.2.4. mRNA Vaccines and Therapeutics Market, by End-User, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics
- 3.1. mRNA Vaccines and Therapeutics Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rise in prevalence of cancer
- 3.1.1.2. Increase in awareness about vaccination
- 3.1.2. Market Challenges
- 3.1.2.1. Growing demand for therapeutic medicines
- 3.1.3. Market Opportunities
- 3.1.3.1. Developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA
Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global mRNA Vaccines and Therapeutics Market, by MRNA Type
- 6.1. Market Snapshot
- 6.2. Global mRNA Vaccines and Therapeutics Market by mRNA Type, Performance - Potential Analysis
- 6.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by mRNA Type, 2018-2028 (USD Billion)
- 6.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 6.4.1. Nucleoside-Modified mRNA (modRNA)
- 6.4.2. Unmodified mRNA
- 6.4.3. Self-Amplifying mRNA
Chapter 7. Global mRNA Vaccines and Therapeutics Market, by Application
- 7.1. Market Snapshot
- 7.2. Global mRNA Vaccines and Therapeutics Market by Application, Performance - Potential Analysis
- 7.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
- 7.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 7.4.1. COVID mRNA Application
- 7.4.2. Non-COVID mRNA Application
Chapter 8. Global mRNA Vaccines and Therapeutics Market, by End-User
- 8.1. Market Snapshot
- 8.2. Global mRNA Vaccines and Therapeutics Market by End-User, Performance - Potential Analysis
- 8.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
- 8.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
- 8.4.1. Hospitals & healthcare Clinics
- 8.4.2. Research Organisation & Institutions
- 8.4.3. Others
Chapter 9. Global mRNA Vaccines and Therapeutics Market, Regional Analysis
- 9.1. mRNA Vaccines and Therapeutics Market, Regional Market Snapshot
- 9.2. North America mRNA Vaccines and Therapeutics Market
- 9.2.1. U.S. mRNA Vaccines and Therapeutics Market
- 9.2.1.1. mRNA Type breakdown estimates & forecasts, 2018-2028
- 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
- 9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
- 9.2.2. Canada mRNA Vaccines and Therapeutics Market
- 9.3. Europe mRNA Vaccines and Therapeutics Market Snapshot
- 9.3.1. U.K. mRNA Vaccines and Therapeutics Market
- 9.3.2. Germany mRNA Vaccines and Therapeutics Market
- 9.3.3. France mRNA Vaccines and Therapeutics Market
- 9.3.4. Spain mRNA Vaccines and Therapeutics Market
- 9.3.5. Italy mRNA Vaccines and Therapeutics Market
- 9.3.6. Rest of Europe mRNA Vaccines and Therapeutics Market
- 9.4. Asia-Pacific mRNA Vaccines and Therapeutics Market Snapshot
- 9.4.1. China mRNA Vaccines and Therapeutics Market
- 9.4.2. India mRNA Vaccines and Therapeutics Market
- 9.4.3. Japan mRNA Vaccines and Therapeutics Market
- 9.4.4. Australia mRNA Vaccines and Therapeutics Market
- 9.4.5. South Korea mRNA Vaccines and Therapeutics Market
- 9.4.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
- 9.5. Latin America mRNA Vaccines and Therapeutics Market Snapshot
- 9.5.1. Brazil mRNA Vaccines and Therapeutics Market
- 9.5.2. Mexico mRNA Vaccines and Therapeutics Market
- 9.6. Rest of The World mRNA Vaccines and Therapeutics Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Gennova Biopharmaceuticals Ltd
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. ProductSummary
- 10.2.1.5. Recent Developments
- 10.2.2. Arcturus Therapeutics Holdings Inc.
- 10.2.3. Providence Therapeutics
- 10.2.4. CureVac N.V.
- 10.2.5. GlaxoSmithKline plc
- 10.2.6. Pantherna Therapeutics GmbH
- 10.2.7. Silence Therapeutics
- 10.2.8. Ethris GmbH
- 10.2.9. BioNTech
- 10.2.10. Versameb AG
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption